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Abstract 
 
 
 The purpose of this study was to develop and validate the Zahn-Given Recovery 
Beliefs Questionnaire (RBQ).  The RBQ is a formal measure designed to assess specific 
underlying beliefs and expectations that relate to treatment non-adherence and recidivism in 
adult psychiatric patients. A total of 100 subjects were administered the RBQ, the Beck 
Hopelessness Scale (BHS), the Dysfunctional Attitudes Scale (DAS); included as well are 
self and clinician-rated compliance with treatment measures.  Factor analysis of the RBQ 
reveals a factor structure that includes four factors: Embarrassment/ Stigma, Unrealistic 
Optimism, Hopelessness/ Pessimism and Concerns About Side Effects.  A total scale alpha 
reliability of .82 indicates stability of the instrument.  The RBQ demonstrates construct 
validity as evidenced by positive correlations with the BHS and DAS, which also measure 
distorted styles of thinking.  Furthermore, the Pessimism/ Hopelessness factor of the RBQ 
correlates positively with the BHS.  Recidivists (n = 31) did not significantly differ from 
non-recidivists (n = 69) on total RBQ score, although non-recidivists endorsed more 
concerns related to the use of psychiatric medications as measured by the Concerns About 
Side Effects Factor of the RBQ.  Treatment implications and recommendations for future 
research are discussed. 
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Psychometric Development and Validation of the Zahn-Given Recovery Beliefs 
Questionnaire In an Adult Psychiatric Sample 
 
Introduction 
 
Among those admitted to psychiatric hospitals are a subgroup of psychiatric patients 
who are sometimes referred to as "revolving door" patients. This term refers to those patients 
who have a high number of hospital admissions compared with other psychiatric patients.  
Researchers have identified patients with three or more admissions within a twelve to 
eighteen month period as recidivists; that is those frequently utilizing inpatient psychiatric 
services.   This phenomenon is frequently related to non-adherence to prescribed medication 
or to treatment.  Nelson, Maruish and Axler (2000) report that patients who fail to engage in 
outpatient treatment, post discharge, are two times more liable to be rehospitalized than 
patients who keep at least one outpatient appointment.  Aggregated annual rates from this 
study indicate that patients who kept their outpatient appointments had a one in ten chance of 
being rehospitalized, and there was a one in four chance for those who did not.  Furthermore, 
Casper, Romo and Fasnacht (1991) report that 24% - 43% of patients who do not adhere to 
treatment will be routinely readmitted to psychiatric facilities.  Current estimates on 
recidivism rates for psychiatric patients are not well documented, although it is believed that 
30-60% of patients receiving medical care do not adhere to recommended treatment 
(Meichenbaum & Turk, 1987).   
In reviewing the research on recidivism, several explanations have been proposed.  
Demographic data suggest that utilization of inpatient services tends to occur more frequently 
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in patients who are male, are younger than 40 years old and have never married (Casper & 
Donaldson, 1990; Green, 1988; Carpenter et al., 1985).  Some researchers speculate that 
recidivism is the result of housing problems, financial problems, or other psychosocial 
stressors (Surber et al., 1987; Harris, Bergman, & Bachrach, 1986).  These characteristics, 
however, do not seem to identify or to predict readmission reliably because they are common 
problems for many psychiatric patients.  In fact, Goodpastor and Hare (1991) found that 
fewer than 5% of hospitalized patients have any identifiable psychosocial stressors that 
preceded hospitalization.  
Two factors that have been consistently identified with recidivism are non-
compliance with medication and aftercare, and drug or alcohol use (Owen et al., 1996; 
Haywood et al., 1995; Goodpastor & Hare, 1991; Casper & Donaldson, 1990; Green, 1988; 
Surber, et al., 1987; Geller, 1986; Harris, Bergman, & Bachrach, 1986; Carpenter, et al., 
1985).  Therefore, it important to understand the cognitive factors underlying these behaviors 
in an effort to reduce the need for frequent admissions to psychiatric facilities. 
Although non-compliance is a common reason for hospitalization, many psychiatric 
patients require re-admission to psychiatric facilities despite adherence to recommended 
treatment.  This can be the result of a an exacerbation of psychiatric symptoms caused by 
specific life stressors, such as financial problems, marital problems, unemployment, chronic 
medical conditions, loss of loved ones, etc.  Relapse rates for major depression, for instance, 
have been estimated at 50% for patients with one prior depressive episode and 80-90% for 
those with two prior episodes (Delgado, 2000).  Despite these numbers, the majority of 
clinically depressed patients discontinue their medication within the first six months of 
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treatment (Delgado, 2000).  Many patients discontinue treatment because of specific beliefs 
they have about their depression or its treatment.   
Patients’ beliefs about the recommended treatment itself are considered to be 
important in understanding treatment non-adherence and recidivism. Using a cognitive 
behavioral perspective based on Beck’s (1976) Cognitive Therapy for depression, clinicians 
are able to formulate a meaningful conceptual model for understanding treatment non-
adherence.  One premise of Cognitive Therapy is that thoughts or interpretations of events 
influence feelings and behaviors.  Beck (1976) observed that the thoughts of depressed 
patients were often distorted or exaggerated.  These errors in logic or cognitive distortions 
have been seen in patients with a variety of clinical disorders (see Table 1). Cognitive 
Therapy asserts that modification of distorted or irrational beliefs can result in improvements 
in one’s mood and changes of behavior.   
In understanding treatment non-adherence, it is important to identify quickly the 
beliefs that may influence patients to discontinue treatment.  The decision to stop treatment 
may result from distorted beliefs patients have about the treatment itself.  For example, some 
patients may think, “Taking medication for my depression means I am weak.”(labeling) or “I 
should be able to handle this on my own” (should statement).   Others may think, 
“Medications that have side effects can’t be good for you” (overgeneralization). Identifying, 
evaluating and modifying these types of distorted beliefs is believed to be an important 
process in enhancing treatment adherence by allowing patients to have more realistic 
expectations regarding psychiatric treatment. 
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Table 1 
Commonly Observed Cognitive Distortions 
Cognitive Distortion Definition 
Dichotomous thinking  Things are seen in terms of two mutually exclusive categories with 
no “shades of gray” in between. 
Overgeneralization A specific event is seen as being characteristic of life in general 
rather than as being one event among many. 
Selective abstraction One aspect of a complex situation is the focus of attention, and other 
relevant aspects of the situation are ignored. 
Disqualifying the positive Positive experiences that would conflict with the individual’s 
negative views are discounted, declaring that they “don’t count.” 
Mind reading The individual assumes that others are reacting negatively without 
evidence that this is the case. 
Fortune telling The individual reacts as though his or her negative expectations 
about future events are established facts. 
Catastrophizing Negative events that might occur are treated as intolerable 
catastrophes rather than being seen in perspective. 
Minimization Positive characteristics or experiences are treated as real but 
insignificant. 
Emotional reasoning Assuming that emotional reactions necessarily reflect the true 
situation. 
“Should” statements The use of should and have-to statements to provide motivation or 
control behavior. 
Labeling Attaching a global label to oneself rather than referring to specific 
events or actions. 
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Personalization  Assuming that one is the cause of a particular external event when, 
in fact, other factors are responsible. 
Note. Adapted from Freeman, Pretzer, Fleming & Simon (1990). Clinical applications of cognitive 
therapy (p. 5). New York: Plenum Press.  
 
 
Statement of the Problem 
 
There is little research exploring the attitudes and beliefs of psychiatric patients that 
lead to noncompliance with treatment.  Such beliefs about illness and the process of recovery 
are believed to be important in understanding noncompliance with aftercare.  Meichenbaum 
and Turk (1987) discussed the importance of assessing patient beliefs in facilitating treatment 
adherence.  They contended that non-adherence may be the result of distorted thinking, 
misconceptions, lack of understanding, faulty information and cultural myths.  Additionally, 
fear, guilt, shame, and “paralysis of will” often contribute to non-adherence (Meichenbaum 
and Turk, 1987). Paralysis of will is a term “first used by Beck to describe extreme 
depression and it was used to convey an amotivational state with severe perceived barriers to 
initiating any efforts” (D. Meichenbaum, personal communication, August 2, 2003).  Table 2 
describes common reasons related to treatment non-adherence. 
Horne (1997) identifies two types of non-adherence: unintentional and intentional 
non-adherence.  Unintentional non-adherence results from patients forgetting, from poor 
understanding of treatment instructions, or from specific illness-related deficits (e.g., 
impaired cognitive functioning).  On the other hand, intentional non-adherence results from a 
"rational" decision made by patients, which is typically justified by a variety of reasons.  For 
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example, patients may deny the existence of a problem or minimize the fact that they have a 
psychiatric condition that warrants continued treatment.  They may blame others as the 
source of the problem while denying any personal responsibility.  Some patients may have 
faulty expectations regarding the course of treatment (e.g., thinking that an anti-depressant 
medication will work in a few days, or thinking that feeling better is an indication that 
treatment is no longer needed, etc.).  Often inpatient psychiatric patients will report that they 
stopped taking their medication prior to being re-hospitalized.  The reason frequently given is 
that that they were feeling better so they thought that they no longer needed their medication 
(e.g., "Why should I take medication if I'm feeling better?").  Such distorted beliefs and 
cognitions, if made the primary focus of treatment for psychiatric recidivists, could 
potentially reduce the need for readmission as the result of treatment noncompliance.  
 
Table 2 
 
Factors Related to Treatment Non-Adherence 
 
Uncertainty about the efficacy of treatment 
Prior experience with illness and changes in patient’s health 
Expectations about symptoms, illness, health care providers, and treatment 
Past experiences with health care providers 
Concerns about possible side effects 
Determination that costs outweigh benefits 
Embarrassment about being in treatment 
Pessimism or skepticism about the effectiveness of treatment 
Impatience with the level of progress or the treatment process 
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Competing demands that are deemed more important 
Paralysis of will 
Viewing treatment as interfering with future plans, relationships, self-concept or daily life 
Note. Adapted from Meichenbaum & Turk, (1987). Facilitating treatment adherence: A 
practitioner’s guidebook.  New York & London: Plenum Press. 
 
Theoretical Background & Related Research 
 
The health belief model. 
 
One theoretical construct for understanding health-related behaviors (e.g., treatment 
compliance) is the Health Belief Model (HBM) (Rosenstock, 1966, 1974).  The HBM 
postulates that treatment compliance is related to patients' beliefs about personal vulnerability 
or susceptibility to the illness, the perceived severity of the illness, beliefs about the efficacy 
and benefits of treatment, and the costs associated with compliance (Rosenstock, 1966, 
1974).  Contemporary researchers have explored the utility of the HBM in understanding 
medication compliance.  For example, Budd, Hughes and Smith (1996) found that perceived 
severity of the illness, personal susceptibility and benefits of treatment are related to 
compliance although beliefs about the costs of treatment are not.  This study also found that 
insight in to one's psychiatric condition is not a significant predictor of compliance with 
treatment.  Similarly, other researchers have found that compliance with medication for 
patients with schizophrenia is independent of level of insight (Garavan et al., 1998);others 
report, however, that compliance is strongly related to attitudes to treatment and insight 
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(Kemp et al., 1996).  Furthermore, Meichenbaum and Turk (1987) report that knowledge 
about one's illness is not significantly related to treatment adherence. 
 
The self-regulation model. 
 
Other researchers have postulated a “common-sense model of illness cognition”, 
which represents a conceptualization of the processes involved in adapting to illness-related 
threats (Leventhal, Diefenbach & Leventhal, 1992, p. 144).  They postulate that treatment 
adherence or non-adherence results from an interaction among representations of health 
threats, emotional reactions and coping procedures.  They suggest that there are two largely 
independent processing systems, one comprising the objective representations of health 
threats and coping procedures and the other the subjective or emotional processing system, 
which is geared toward the management of emotions. Together these two processing systems 
compose the self-regulation model (SRM) (Leventhal, Diefenbach & Leventhal, 1992).  They 
suggest that representations of the illness heavily influence health-related behavior and 
coping responses.  The SRM identifies representations or beliefs about illness into five 
components: Identity (What caused it?), Time-line (How long will it last?), Consequences 
(How has it/will it affect me?), and Cure/Control (Can it be controlled or cured?).   The 
authors suggest that adherence to treatment is high when both the patient and practitioner 
have similar representations of the illness and agree upon treatment methods and criteria for 
evaluating outcome.  Conversely, adherence is low when differences in beliefs exist between 
patient and practitioner.   
 
14 
 
The working alliance & adherence. 
 
One method for increasing adherence is to understand the importance of the 
therapeutic alliance.  In 1976, Edwin Bordin published a paper on the therapeutic alliance 
that addressed the importance of the therapeutic relationship across all types of therapy.  
Bordin believed that the concept of the alliance was generic to all forms of therapy.  He 
stated that the alliance involved agreement between patient and therapist, making it a more 
collaborative relationship than those that others have reported (Rogers, 1951).  Bordin (1976) 
describes the alliance in terms of three components: agreement on goals, on tasks, and on 
developing an interpersonal bond.  Agreement on treatment goals consists of both short-term 
and long-term expectations between patient and therapist.  Bordin (1994) also states that 
negotiation is an integral part in this process.  The treatment goals need to be realistic and 
should be mutually agreeable to both patient and therapist.   
The establishment of goals is crucial in determining the effectiveness of treatment.  
Goals must be measurable and realistic for patients, yet provide a focus for treatment.  Once 
meaningful goals have been established the therapeutic tasks are negotiated.  The tasks refer 
to the methods that will be employed throughout the course of treatment to help patients 
achieve their goals.  Bordin (1994) describes the therapeutic tasks as, "the specific activities 
that the partnership will engage in to instigate or facilitate change" (p.17). This would 
include such things as frequency of visits, time limits, homework, specific techniques and so 
on.  Bordin pointed out that the patient must understand the relevance of these tasks to their 
goals in order to remain an active partner in treatment.  Also, both patient and therapist must 
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assume responsibility for these acts and their own behaviors as they relate to the goals of 
treatment.  
The third component of the working alliance is the establishment of an interpersonal 
bond between patient and therapist.  This bond develops out of trust, respect and a sense of 
common purpose.  Obviously, this can be a slow and delicate process for some patients who 
have a weak capacity for forming relationships.  If a bond is not formed with patients then 
they may withhold important information that would otherwise be revealed.  Developing a 
positive working alliance allows patients to be committed to treatment while enhancing 
adherence and treatment efficacy (Bordin, 1976; Horvath & Luborsky, 1993).  
 
Stages of change. 
  
 Another model for understanding adherence to treatment is Prochaska & 
DiClemente's (1982) transtheoretical model of change.  This model has shown success in 
applications to smoking cessation, weight loss, and alcoholism; however, its usefulness 
extends to understanding premature termination of psychiatric treatment.  As previously 
mentioned, non-adherence to recommended treatment is highly correlated with psychiatric 
recidivism.   
 The stages of change model includes five stages: precontemplation, contemplation, 
preparation, action and maintenance.  In pre-contemplation the individual is not aware of the 
problem or has no desire to change the behavior.  In contemplation, however, the individual 
is aware that a problem exists but has made no formal decision to change.  Preparation 
involves the decision to take action on a particular problem, as opposed to the action stage in 
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which the person begins to change his or her behavior effectively.  Preventing relapses or 
consolidating previous changes is the aim of the maintenance stage.   
Evaluating patients' readiness to change at the onset of treatment may help determine 
how effective the treatment will be. The person’s particular stage of change will, in part, 
influence his or her ability to follow through on treatment recommendations.  Individuals in 
the preparation, action, or maintenance stage may be more likely to remain compliant than 
those in the pre-contemplation or contemplation stage because they have already 
implemented the change process.  In fact, Smith, Subich, and Kalodner (1995) found that 
premature termination of therapy among college students is more likely for those in the pre-
contemplative stage.  This finding may have applications in explaining frequent treatment 
failures among psychiatric inpatients.  Knowledge of patients' readiness to change is an 
important factor in evaluating appropriate treatments and predicting adherence. 
 
The role of beliefs. 
 
Horne (1999) stresses the importance of patient beliefs in treatment outcome.  He 
suggests that treatment outcome is the result of an interaction between patients’ beliefs about 
the illness, beliefs about treatment and perceived outcome from treatment.  Furthermore, he 
states that  patients’ beliefs about illness influence their decisions regarding the necessity of 
treatment, and that negative beliefs about medication are linked with noncompliance.  For 
instance, many patients view medications as harmful and overused by doctors.  Others may 
have overly positive views of medication that can lead to inappropriate demands for 
medication or to its inappropriate use.  In an earlier study, Horne (1997) found that concerns 
17 
 
about medication were related to non-adherence even when medication was believed to be 
necessary and effective. Some of the medication-related concerns refer to their actual or 
perceived potential for addiction or dependence, beliefs that medications are unnatural and 
overused by physicians, and concerns about their long-term negative or harmful effects.  
Horne points out that such medication-related beliefs might influence patients’ decisions 
about other auxiliary treatments.  He suggests using the necessity-concerns construct as a 
way of understanding patient beliefs.  This involves evaluating patients’ beliefs about the 
necessity of treatment yet eliciting any concerns related to the treatment.  Although this 
construct seems to be useful in understanding patient beliefs, there appears to be no formal 
way of assessing these beliefs with psychiatric patients.   
Weinman and Petrie (1997) also discussed the importance of assessing patient' beliefs 
about their illnesses.  They believe that it is important to assess these beliefs or illness 
perceptions early in treatment because of their relationship to adherence, emotional distress 
and illness related disability.  Similarly, others have found that distorted or irrational health 
related beliefs can influence adherence to treatment or discounting of medical advice 
(Christensen, Moran & Wiebe, 1999). Others have suggested a self-regulatory model in 
understanding treatment adherence.  This includes cognitive representations of the illness, 
including beliefs about the etiology of the illness, its symptoms, personal consequences of 
the illness, perceived duration, and the amenability of the illness to control or to cure 
(Leventhal, Nernez & Steele, 1984; Leventhal, Diefenbach & Leventhal, 1992).  These 
underlying cognitive representations help patients make sense of their own experiences and 
guide their coping responses.  Similarly, Marlatt and Gordon (1985) have discussed the 
importance of cognitive factors in the process of recovery from substance abuse or 
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dependences, which includes self-efficacy (e.g., subjective sense of control or ability to 
cope), outcome expectancies (e.g., anticipated effects) and attributions about lapses and 
relapses. 
Other cognitive and personality factors influencing health related behaviors are health 
locus of control (Wiebe & Christensen, 1996), trait conscientiousness (Booth-Kewly & 
Vickers, 1994) and unrealistic optimism (Weinstien, 1982, 1983, 1984). According to Locus   
of control, a social learning theory construct (Rotter, 1966), peoples’ expectations of 
desirable outcomes may be contingent, in varying degrees, upon their own behavior or as the 
result of external factors. Because locus of control appears to be a generalized and stable 
personality characteristic, it can be a useful concept in understanding health-related behavior.  
A number of studies have looked at the association between locus of control and adherence 
with mixed results, although some studies find that medical patients with higher internal 
locus of control are more likely to adhere to treatment (Wiebe & Christensen, 1996).  
Conscientiousness refers to the tendency to be goal and future oriented, responsible and 
reliable.  Conscientious individuals are able to delay immediate gratification and are 
disciplined in the pursuit of long-term goals.  Not surprisingly, conscientiousness has been 
found to be a strong predictor of health-related behaviors (Booth-Kewly & Vickers, 1994).  
Additionally, cognitive appraisals of susceptibility to health risks are believed to be 
important in understanding adherence to treatment.  Studies have shown that some people are 
unrealistic about their vulnerability to health risks and demonstrate an optimistic bias 
(Weinstien, 1982, 1983, 1984).  This unrealistic optimism can lead to premature termination 
of treatment, or can result in an expectation that professional treatment is not needed.  The 
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ability to identify and correct such distorted cognitive representations of illness and recovery 
is an important component in increasing patient compliance with treatment. 
 
Purpose of the Study 
 
The purpose of this study is to develop the Zahn-Given Recovery Beliefs 
Questionnaire (RBQ) originally developed by B. Zahn (personal communication, October 
2001), and to show that it has adequate psychometric properties.  The RBQ is being 
developed to assess beliefs and attitudes toward recovery and aftercare in psychiatric 
patients.  Similar instruments have been developed within the addiction field (Myers, Martin, 
Rohsenow, & Monti, 1996; Miller & Tonigan, 1996) as well as for use with medical patients 
(Christensen, Moran, & Wiebe, 1999; Horne, 1999; Weinman, Petrie, Moss-Morris & Horne, 
1996).  Cochran and Gitlin (1988) developed a scale to assess specific beliefs related to 
Lithium compliance in patients with bipolar disorder; however, to date, no scales have been 
developed to assess the general recovery beliefs of psychiatric patients.  The proposed scale 
will be used to assess how well patients understand the process of recovery for their 
psychiatric condition, as well as their need for ongoing aftercare.  
 
Importance of study 
 
 There are a number of reasons why it is important to develop interventions to reduce 
psychiatric recidivism. The costs of recidivism are many, including its impact upon 
individuals, families, communities, and society; these costs also extend to its economic 
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impact.  On an individual level, patients who are routinely readmitted to hospitals may have 
significantly diminished self-esteem or self-worth.  They may also possess feelings of 
inadequacy, inferiority, hopelessness and helplessness.  Many recidivists may develop 
dependence on others, including families and institutions, believing that they are incapable of 
managing life on their own.  Family relationships may become strained from the frustration 
that many might feel towards patients who are seemingly incapable of leading productive 
lives.  As patients perceive that their support systems diminish, they may become more 
desperate and more liable to be re-hospitalized in the future as their only safe haven.  Once 
hospitalized, discharge planning becomes complicated by the fact that some of the supports 
that the patients once had are no longer available to them.  The result may be that patients 
whose families refuse to take them back are discharged with inadequate housing, and find it 
necessary to live in a boarding home or a shelter.  This change in housing and disruption of 
family support makes it more likely for these patients to require re-hospitalization in the 
future.   
More broadly, the community and societal impact is that recidivism may help to 
promote the stigma of mental illness, reinforcing the belief that people with mental illness are 
incapable of leading functional lives. The economic impact can be seen by the decreased 
reimbursement rates, the denial of covered services and shorter lengths of inpatient stay, 
resulting in an overall reduction in the quality of care given to these patients. Furthermore, 
many psychiatric patients are unemployed or disabled and may not have sufficient financial 
resources available to them.  In fact, mental illness ranks as the number one cause of 
disability in the United States, Canada and Western Europe (WHO, 2001).  Of those 
receiving disability benefits, many have little to no disposable income to put back into the 
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economy.  The Department of Health and Human Services (1999) has estimated that the 
economy’s loss of productivity from mental illness amounts to $63 billion annually. Given 
the many costs of recidivism, it is important to develop interventions aimed at reducing non-
adherence and recidivism among psychiatric patients.  The present study aims to investigate 
cognitive factors related to recidivism that may be amenable to psychological interventions. 
 
Specific Hypotheses 
 
1. The Zahn-Given Recovery Beliefs Questionnaire (RBQ) will demonstrate content 
validity as established by a panel of independent experts. 
2. The RBQ will demonstrate construct validity as evidenced by a factor structure that 
includes pessimism or negative expectations about treatment, concerns about side effects, 
perceived disadvantages of treatment, embarrassment, and unrealistic optimism. 
3. Total score of the RBQ as well as its subscales will possess a coefficient alpha of at least 
.70. 
4. Recidivists will significantly differ from non-recidivists on total RBQ scores.  
5. Total RBQ scores will be positively correlated with Beck Hopelessness Scale (BHS) 
scores.  In addition, high unrealistic optimism scores on the RBQ will show an inverse 
relationship to BHS scores. 
6. Total RBQ scores will be positively correlated with total Dysfunctional Attitude Scale 
(DAS) score. 
7. Total RBQ scores will be negatively correlated with treatment compliance scores. 
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8. Total RBQ scores for patients who are non-compliant with treatment will be significantly 
higher from those who seek treatment and drop out prematurely, regardless of the number 
of previous psychiatric admissions.   
9. The cognitive variables that correlate the highest with recidivism will be hopelessness 
(total BHS score) and unrealistic optimism (RBQ subscale score). 
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Method 
 
Participants 
 
Subjects were recruited from a group of psychiatric inpatients from Friends Hospital 
in Philadelphia, PA.  The primary unit patients were selected from was East 2, an acute 
inpatient adult unit serving male and female patients ranging in age from 18-65.  
Demographic data was obtained including age, gender, psychiatric diagnosis, level of 
education, degree of compliance with outpatient care and number of hospitalizations in the 
previous year.  All subjects volunteered to participate in the study and were able to withdraw 
at any time.  
Participants eligible for the study were those with a primary diagnosis of major 
depressive disorder, bipolar disorder, schizophrenia, schizoaffective disorder, obsessive-
compulsive disorder, post-traumatic stress disorder, panic disorder, generalized anxiety 
disorder, borderline personality disorder and other mood and psychotic disorders.  Subjects 
with a co-morbid diagnosis of substance abuse or dependence were also included.  Patients 
excluded from the study were those who had a primary diagnosis of delirium, dementia, 
mental retardation or other cognitive disorders.  These patients were not included in the study 
because of their impaired cognitive functioning. The admission psychiatric evaluation was 
used to determine eligibility using DSM-IV-TR criteria (APA, 2000).  Patients who left the 
hospital before completing treatment (e.g., elopement, discharged against medical advice, 
etc.) were not included in the study. 
 Subject variables were used to determine recidivists and non-recidivists.  Criteria for 
recidivists included those patients who have had three or more inpatient admissions in the 
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previous 12 months, or those readmitted to a psychiatric hospital within 90 days of their last 
discharge.  Hospital records were used to verify admission data.  Additionally, dates of 
admission to other psychiatric facilities were obtained from the patient as well as from the 
patient’s insurance carrier (if applicable) to capture hospitalizations at other institutions.  
Non-recidivists were those patients with fewer than three psychiatric admissions within the 
prior year, or those with more than 90 days between two separate admissions.  
Hospitalization information was verified whenever possible to establish the reliability of the 
data. 
 
Overview of Research Design 
 
The present study is correlational by design and consists of two separate phases.  The 
first phase involved using a panel of independent experts to formally develop the RBQ.  The 
second phase involved administering the RBQ to patients to establish its psychometric 
properties.  Subjects were administered the RBQ upon admission to the hospital and one 
week later, or on the day of their discharge, whichever came first.  Subject responses to the 
RBQ were correlated with several patient factors, including compliance with outpatient 
treatment, adherence to prescribed psychiatric medication, number of hospital admissions in 
the previous year, and total number of days hospitalized in the previous year.  Additional 
measures were correlated with RBQ scores, including the Beck Hopelessness Scale (Beck et 
al., 1974) and the Dysfunctional Attitudes Scale (Weissman, 1979).  
 
Development of the RBQ 
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Item generation and selection. 
 
Test items were derived from a review of relevant literature.  Several sources were 
used to generate scale items, including discussions with patients, psychologists, psychiatrists, 
social workers and psychiatric nurses in inpatient settings who were experienced in working 
with this patient population.  Furthermore, the factors involved in non-adherence as proposed 
by Meichenbaum & Turk (1987) were used as a basis for generating scale items.  Content 
areas were presented in an effort to reflect the “universe” of cognitive factors leading to 
treatment non-adherence or to subsequent treatment failure.  Some of the content areas under 
investigation included uncertainty about treatment, past experience with symptoms, past 
experience with health care providers, expectations about treatment, concerns about side 
effects, perceived disadvantages of treatment, embarrassment, pessimism, impatience, and 
unrealistic optimism. . Appendix A reflects the proposed scale items prior to expert review. 
 
Scale construction & expert review. 
 
Three independent experts were used to review the proposed content areas and scale 
items.  Each expert reviewer was a doctoral-level mental health professional, having a 
minimum of five years experience with inpatient psychiatric patients. The expert review 
process involved several steps.  The first step was to review the proposed variables or content 
areas (See Table 3). The task of the reviewers was to decide whether or not the proposed 
variables reflected the “universe” of cognitive factors believed to be important in the process 
of recovery.  An additional category regarding the “therapeutic alliance” was proposed for 
inclusion by one of the reviewers; however, the two other experts believed that this was 
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subsumed under other variables.  Two variables, “paralysis of will and “hostility” were 
eliminated during the review process.  Of the major content areas selected for final inclusion 
in the instrument, a criterion of 100% agreement between independent experts was achieved 
(see Table 4).   
 
Table 3 
Proposed Variables Prior to Expert Review 
 
Uncertainty about the efficacy of treatment 
Prior experience with illness and changes in patient’s health 
Expectations about symptoms, illness, health care providers, and treatment 
Past experiences with health care providers 
Concerns about possible side effects 
Determination that costs outweigh benefits 
Embarrassment about being in treatment 
Pessimism or skepticism about the effectiveness of treatment 
Impatience with the level of progress or the treatment process 
Competing demands that are deemed more important 
Paralysis of will  
Viewing treatment as interfering with future plans, relationships, self-concept or daily life 
Unrealistic Optimism 
Hostility  
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Once agreement was achieved on the content areas, the reviewers examined the 
definitions of each content area to assure that each definition accurately reflected the 
proposed cognitive domain.  Reviewers indicated this by a “Yes” or “No” response.  
Definitions were reviewed and modified based upon input from the review process.  This 
process was repeated until a criterion of 100% agreement on the definitions of the content 
areas was achieved. (see Table 5). 
 
Table 4 
Selected Variables Following Expert Review  
 
Uncertainty about the efficacy of treatment 
Prior experience with illness and changes in patient’s health 
Expectations about symptoms, illness, health care providers, and treatment 
Past experiences with health care providers 
Concerns about possible side effects 
Determination that costs outweigh benefits 
Embarrassment about being in treatment 
Pessimism or skepticism about the effectiveness of treatment 
Impatience with the level of progress or the treatment process 
Competing demands that are deemed more important 
Viewing treatment as interfering with future plans, relationships, self-concept or daily life 
Unrealistic Optimism 
 
 
28 
 
Table 5 
 
Variables and Definitions Following Expert Review 
 
Variable 
 
Definition 
 
1. Uncertainty about the efficacy of 
treatment 
Not being sure that treatment will do what I want it 
to. 
2. Prior experience with illness and 
changes in patient’s health 
Beliefs about recovery that arise out of past 
improvements and setbacks. 
3. Expectations about symptoms, 
illness, health care providers, and 
treatment 
Beliefs related to the course of an illness, control 
over related symptoms and generalized beliefs 
about therapists, psychologists, psychiatrists and 
psychiatric/psychological treatment. 
4. Past experiences with health care 
providers 
Beliefs that arise out of positive and negative 
experiences with therapists, psychologists, and 
psychiatrists that influence the likelihood of 
seeking psychiatric/psychological treatment and/or 
staying with the current course of treatment. 
5. Concerns about possible side 
effects 
Fears or worries about experiencing negative 
outcomes from medication or psychotherapy (e.g., 
physical discomfort, emotional distress, 
relationship difficulties, etc.) 
6. Determination that costs outweigh 
benefits 
Deciding that there are more disadvantages to 
psychiatric or psychological treatments than there 
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are advantages (e.g., cost, stigma, time constraints, 
shame, etc.) 
7. Embarrassment about being in 
treatment 
Resistance or reluctance to engage in treatment 
based on fear of negative evaluation from others. 
8. Pessimism or skepticism about the 
effectiveness of treatment 
Thinking that treatment (medication or therapy) is 
not very likely to help or won’t help at all. 
9. Impatience with the level of 
progress or the treatment process 
Feeling frustrated with a lack of significant 
progress within an expected time frame, which 
influences a person’s willingness to stay with the 
treatment. 
10. Competing demands that are 
deemed more important 
Thinking that your time and energy is better spent 
on things other than treatment (e.g., work, 
childcare, household responsibilities, etc.) 
11. Unrealistic optimism Having overly simplistic and naïve beliefs about 
how stay emotionally healthy, well and/or stable. 
 
 
Once the content areas had been established, the proposed scale items were subjected 
to expert review.  The first step in this process was to have the proposed items examined for 
grammar and clarity.  Items were presented in a random sequence rather than under a 
presumed category.  Reviewers decided if an item was clear, understandable and 
grammatically correct by indicating “Yes”, “No” or “Reword”.  Items were retained, 
discarded or reworded as needed. Items receiving 100% agreement were automatically kept. 
Eleven items were judged to be acceptable by two out of three reviewers.  These items were 
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reworded and resubmitted for review and 100% agreement among reviewers was achieved 
for the revised items. However, four items were discarded because only one of the three 
reviewers found those items acceptable. 
The next step in the review process was to have each of the reviewers independently 
sort the items into the proposed content areas.  Reviewers were provided with a list of the 
proposed categories, including their definitions.  The task of the reviewers was to read each 
item carefully and to decide into which category to place the item.  Items were printed on 
individual cards so that they could be sorted into piles corresponding to the proper category.   
Once completed, the items were reviewed to ascertain that they had placed them in the proper 
category.  Reviewers were instructed to include only those items that should be retained for 
the final instrument.  A “discard” category was included as an option during this sorting 
process.  The 20 items retained for the final instrument reflect 100% agreement in the sorting 
of items. These items were then randomly sorted, thus making up the final instrument (See 
Appendix B).   
  
Scale Administration 
 
Subjects were administered the Zahn-Given Recovery Beliefs Questionnaire (RBQ), 
the Dysfunctional Attitude Scale- A (DAS-A) (Weissman, 1979) and the Beck Hopelessness 
Scale (BHS) (Beck et al., 1974).  The scales were administered in the above order within 24 
to 48 hours of admission to the hospital. Informed consent was obtained for all participants 
before collecting any data. Demographic data and hospitalization history was also collected 
in collaboration with the hospital utilization review staff.  Compliance with treatment scales 
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were completed by both the subject (Appendix C) and a treating clinician (i.e., psychiatrist, 
therapist, social worker or psychiatric nurse) (Appendix D).  A total compliance with 
treatment score was calculated for each scale based on these data. 
 
Measures 
 
 Zahn-Given Recovery Beliefs Questionnaire (RBQ) 
 
 
 The Zahn-Given Recovery Beliefs Questionnaire (Zahn & Given, 2002) is a 20 item 
self-report measure of beliefs related to recovery from psychiatric illness.  The RBQ is 
composed of short statements that reflect beliefs related to psychiatric treatment and 
recovery.  Responses are made on a 5 point Likert scale from 0 = not at all to 4 = totally.  
Additionally, respondents had the option of selecting “does not apply” for each individual 
item. 
 
Beck Hopelessness Scale (BHS). 
 
The Beck Hopelessness Scale (BHS) (Beck, et al., 1974) is being used to establish 
construct validity.  The BHS, a self-report measure, consists of 20 true-false items that assess 
patients’ level of hopelessness about both short term and long term future events.  It has been 
shown to be both a reliable and valid measure of hopelessness having high internal 
consistency (.87—.93) and a 6-week test—retest reliability of .66 ( Beck & Steer, 1988 ). 
The BHS predicts suicidal intent and behavior much better than self-report measures of 
depression alone (Beck & Steer, 1988).  It is believed that high BHS scores will correlate 
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with items of the RBQ that assess hopelessness about recovery.  Furthermore, low scores on 
the BHS should show an inverse relationship to high unrealistic optimism scores on the 
RBQ.   
 
Dysfunctional Attitudes Scale (DAS). 
 
The Dysfunctional Attitudes Scale, Form A (DAS-A) (Weisman, 1979) is being used 
to establish construct validity.  The DAS is a 40-item instrument that measures cognitive 
distortions that underlie depression.  Responses to items are made using a 7-point Likert 
scale ranging from “totally agree” to “totally disagree”. Two versions of the DAS are 
available (Forms A and B) with inter-test correlations between total score and parallel forms 
ranging from .84 to .97.  High scores on the DAS indicate the presence of a distorted thinking 
style, whereas low scores indicate a more adaptive cognitive style. Six-week test-retest 
reliability is .73 and DAS and BDI scores have a correlation coefficient of .41 (Oliver & 
Baumart, 1985).  It is believed that high scores on the DAS will correspond to items on the 
RBQ that reflect a similar distorted thinking style.  
 
Number of previous hospital admissions. 
 
 The number of previous hospitalizations was calculated upon the patient’s admission 
to the hospital.  This number represented hospitalizations within 12 months of the current 
hospital admission.  Data was collected from the patient and verified whenever possible by 
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hospital records or by contacting the patient’s insurance carrier (if applicable) to capture 
hospitalizations at other institutions.  
 
Total days hospitalized. 
 
 The total number of days a patient was hospitalized was calculated for one calendar 
year using the same process as above.  This number was determined after the patient was 
discharged from his or her current hospital admission.  The day of discharge from the current 
hospitalization determined the preceding 12-month period.  For example, the number of days 
hospitalized for a person discharged on 6/5/03 would be calculated starting from 6/5/02.  
Again, an attempt was made to establish the reliability of the data using the method described 
above. 
 
 Compliance with treatment. 
 
 
 A total treatment compliance score was calculated, using patient and clinician ratings 
of statements regarding compliance with outpatient care and adherence with prescribed 
psychiatric medication (See Appendix C & D).  Compliance with outpatient care was based 
on self and other-reports, using a 5 point Likert Scale to assess degree of adherence to 
psychiatric appointments and medication.  Subjects were asked to rate statements regarding 
their compliance with outpatient care and degree of adherence to their psychiatric medication 
using the following scale: 0 = does not apply, 1 = totally agree, 2 = agree somewhat, 3 = 
neutral, 4 = disagree somewhat, 5 = totally disagree. (See Appendix C). Similarly, clinician 
ratings (i.e., psychiatrist, therapist, social worker or psychiatric nurse) were also used to 
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assess degree of adherence. (See Appendix D).  These assessments were also aimed at 
differentiating between patients who did not comply with recommended aftercare compared 
with those who terminated treatment prematurely.  Treatment non-compliance will be 
indicated for patients who did not attend any of their previously recommended aftercare 
appointments (e.g., outpatient therapy, psychiatric appointments, partial hospital, intensive 
outpatient program, etc.) within the previous six months or since their last hospitalization (if 
fewer than 6 months). Premature termination differs from non-compliance, which is defined 
for patients who attended only a few sessions before dropping out altogether. This is an 
important distinction because it is believed that different cognitive variables influence those 
who decide to seek treatment and then drop out, as opposed to those who never seek 
treatment when it is recommended.   Similarly, non-compliance with medication and 
medication misuse need to be differentiated.  Non-compliance with medication will be 
indicated for patients who failed to take any of their prescribed medications in the 6 months 
prior to their current hospitalization or since their last hospitalization (if fewer than 6 
months). This contrasts with misuse of medication, which is designated for patients who have 
taken their medications in a way that is inconsistent with the way in which it is prescribed 
(i.e., reducing or increasing the dose, skipping doses, taking it inconsistently, etc.).   
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Results 
 
 In this section the demographic and diagnostic characteristics of the sample will be 
reviewed.  Compliance with treatment data is also presented here, followed by a factor 
analysis of the RBQ.  Correlational analyses were conducted and the findings are reviewed.  
Furthermore, a reliability analysis of the RBQ is presented. 
 
 
Descriptive Statistics 
 
A total of 100 subjects were used for this study.  Descriptive statistics for the sample 
are presented below.  Table 6 presents demographic data regarding gender, employment 
status, marital status, educational level, housing and ethnicity; and table 7 shows the 
diagnostic characteristics of the sample. 
 
Age.  Ages ranged from 18 to 63 years old.  The mean age for the sample was 37.86 
years with a standard deviation of 10.98.  No significant difference in age was found between 
recidivists and non-recidivists (t = -1.35, df = 98, p < .18). 
 
Gender.  Males composed 73% (n = 73) of the total sample compared with 23% (n = 
23) for females.  Recidivists were comprised of 25 males (81%) and 6 females (19%), 
compared to 48 males (70%) and 21 females (30%) for non-recidivists. 
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Marital status. Marital status distribution consisted of 52 % who were single (n = 52), 
14% who were married (n = 14), 14% who were separated (n =14), 16% who were divorced 
(n =16), and 4% who were widowed (n = 4). 
 
Employment status.  The employment status of the sample reflects that 24% were 
employed full-time (n = 24), 8% were in part-time employment (n = 8), 31 % were 
unemployed (n = 31), and 37% were disabled (n = 37). 
 
Educational level.  The level of education subjects achieved reflects 22% of the 
sample who never finished high school (n = 22), 31% were high school graduates (n = 31), 
9% had a GED (n = 9), 18% had some college experience (n = 18), 12 % were college 
graduates (n = 12), and 8% had a graduate or advanced degree (n = 8).  
 
Housing condition.  The housing condition of the sample reflects a distribution of 
75% who lived independent housing (n = 75), 8% were in supported housing (n = 8), 6% 
were homeless (n = 6), 9% lived in a recovery house (n = 9) and 1% lived in a shelter (n = 1). 
 
Ethnicity.  The ethnic distribution of subjects revealed 15% of the sample was African 
American (n = 15), 75% Caucasian (n = 75), 8% Hispanic (n = 8), and 2% were of other 
ethnic origin (n = 2). 
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Table 6 
 
Demographic Data  
 
 
Age  Educational level 
 
 
     Range 18-63      Never finished high school 
 
22 % 
     Mean 37.86      High school graduate 31 % 
Gender       GED 9 % 
     Male 73 %      Some college 18 % 
     Female 27 %      College graduate 12 % 
Employment status       Graduate/ advanced degree 8 % 
     Full time 24 % Housing condition  
     Part time 8 %      Independent housing 75 % 
     Unemployed 31 %      Supported housing 8 % 
     Disabled 37 %      Homeless 6 % 
Marital status       Shelter 1 % 
      Single 52 %      Recovery house 9 % 
     Married 14 % Ethnicity  
     Separated 14 %      African American 15 % 
     Divorced 16 %      Caucasian 75 % 
     Widowed 4 %      Hispanic 8 % 
       Other 2% 
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Recidivists.  Recidivists accounted for 31 % of the sample (n = 31) compared with 69 
% of non-recidivists (n = 69).    Recidivists were more frequently male (81%, n = 25), single 
(42%, n = 13), and Caucasian (81%, n = 25).  Also, they were more frequently disabled 
(48%, n = 15), high school graduates (35%, n = 11), and lived in independent housing (55%, 
n = 17).   
 
Psychiatric Diagnosis.  The diagnostic characteristics of the sample are presented in 
Table 7 and include mood disorders 75% (n = 75), psychotic disorders 18% (n = 18), anxiety 
disorders 3% (n = 3), and other psychiatric disorders 4% (n = 4).  A secondary diagnosis was 
coded for 46% of the total sample (n = 46), including substance abuse/dependence 34% (n = 
34), personality disorders 5% (n = 5), mood disorders 2 % (n = 2), anxiety disorders 2% (n = 
2) and other psychiatric disorders 3% (n = 3).  Mood disorders were most common among 
recidivists (71%, n = 22) followed by psychotic disorders (26%, n = 8).  Non-recidivists were 
more frequently being treated for mood disorders (77%, n = 53) followed by psychotic 
disorders (14%, n = 10).  Co-morbid substance abuse/dependence accounted for 45% of 
recidivists (n = 14) and personality disorders were present in 10% of this group (n = 3).  
Recidivists did not differ from non-recidivists on primary diagnosis (Chi square = 3.03, df = 
3, p < .386) or secondary diagnosis (Chi square = 2.27, df = 4, p. < .686). 
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Table 7 
 
Diagnostic Characteristics of the Sample 
 
Primary Diagnosis Frequency % 
     Major Depression  29 29 % 
     Bipolar disorder 22 22 % 
     Depressive Disorder NOS 15 15 % 
     Schizophrenia 10 10 % 
      Schizoaffective Disorder 5 5 % 
     Mood disorder NOS 4 4 % 
     Psychotic Disorder NOS 2 2 % 
     Obsessive Compulsive Disorder 2 2 % 
     Panic Disorder 1 1 % 
     Adjustment Disorder NOS 1 1 % 
     Delusional Disorder 1 1 % 
     Impulse Control Disorder NOS 1 1 % 
     Substance Induced Psychotic Disorder 1 1 % 
Secondary Diagnosis Frequency % 
     Substance abuse/dependence 34 34 % 
     Personality disorders 5 5 % 
     Major Depression 1 1 % 
     Obsessive Compulsive Disorder 1 1 % 
     Depressive Disorder NOS 1 1 % 
     Adjustment Disorder with Depressed Mood 1 1 % 
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     Post Traumatic Stress Disorder 1 1 % 
 
Number of hospitalizations.  The total number of hospitalizations subjects had in the 
previous year ranged from 1 to 7 with a mean of 1.94 and a standard deviation of 1.41.  
Recidivists were hospitalized an average of 3.55 times (S.D. = 1.5) compared with 1.20 for 
non-recidivists (S.D. = .41) 
 
Days hospitalized. Total days hospitalized for the previous 12 months ranged from 2 
to 121 with a mean of 15.93 and a standard deviation of 19.33. The median was 9.0 days.  
Recidivists were hospitalized an average of 36.48 days (S.D. = 27.23) compared with 8.66 
for non-recidivists (S.D. = 6.89) 
 
Table 8 
Comparison of Mean Number of Hospitalizations and Total Days Hospitalized 
 
 Recidivist  
 Yes 
 
No 
 
Total 
 
Number of Hospitalizations 3.55 
(N=31) 
1.20 
(N=68) 
1.94 
(N=99) 
SD 1.5 .41 1.41 
Total Days Hospitalized 36.48 
(N=23) 
8.66 
(N=65) 
15.93 
(N=88) 
SD 27.23 6.89 19.33 
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Compliance with treatment.  Table 9 presents data regarding subjects’ compliance 
with treatment.  68% of subjects (n = 68) stated that they had taken psychiatric medication in 
the previous six months or since their last discharge, compared with 32% (n = 32) who did 
not.  50% of the people (n = 16) not taking medication answered “yes” when asked, “Has 
anyone ever recommended that you take psychiatric medication?”  44% (n = 44) said that 
they had not attended outpatient treatment (e.g., therapy, intensive outpatient treatment, 
partial hospitalization, etc.) in the previous 6 months or since their last hospitalization even 
when it had been recommended to 71% of this group (n = 31).  23% said that they did not 
complete their treatment (n = 13) compared with 13% who did (n = 7).  64% (n = 34) said 
that their treatment was still in progress at the time of their hospitalization. 
 
Table 9 
Compliance with Treatment 
 
 
 Frequency % 
Taking medication prior to hospitalization 68 68% 
Not taking medication prior to hospitalization 32 32% 
     Medication previously recommended 16 50% 
Not in outpatient treatment prior to hospitalization 44 44% 
     Treatment previously recommended 31 71% 
Did not complete treatment 13 23% 
Completed treatment 7 13% 
Treatment still in progress 34 64% 
 
42 
 
 
 
 Factor Analysis of the RBQ 
 
A principal components, varimax rotated factor analysis using Kaiser’s Criterion was 
conducted.  The 20 items of the RBQ were analyzed and 6 factors were extracted, accounting 
for 70.06 % of the total variance.  A total scale Coefficient Alpha of .82 demonstrates 
acceptable levels of internal consistency.  Using a factor loading criteria of .55 or greater, 4 
factors were retained, accounting for 56.14 % of the total variance.  These factors are 1) 
Embarrassment/ Stigma (  = .85), 2) Unrealistic Optimism (  = .61), 3) Pessimism/ 
Hopelessness (  = .79), and 4) Concerns About Side Effects (  = .76).  Table 10 presents the 
distribution of the items to corresponding factors and factor loadings for each item. Results 
indicate that items that loaded on these factors closely reflect 4 of the hypothesized subscales 
of the RBQ.   
The first factor, Embarrassment/ Stigma (  = .85), consists of five items.  This factor 
accounts for the largest single variance of all factors on the scale.  This factor appears to 
measure subjective feelings of shame, embarrassment, and fear of negative evaluation by 
others related to the need for psychiatric treatment.  High scores on this factor reflect higher 
levels of embarrassment, shame, and fear on negative evaluation. 
The second factor, Unrealistic Optimism (  = .61), consists of four items.  This factor 
appears to measure overly simplistic and naïve beliefs about how to stay emotionally healthy, 
well and/or stable.  This factor would benefit from further development given its lower alpha 
score.  High scores on this factor reflect more simplistic and naïve beliefs related to recovery 
from mental illness. 
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The third factor, Pessimism/ Hopelessness (  = .79), consists of three items.  The 
items on this factor appear to measure negative expectations regarding the efficacy of 
psychiatric treatment; that is, the extent to which subjects believe that treatment is not likely 
to help them.  High scores on this factor reflect higher levels of hopelessness and pessimism 
related to treatment. 
The fourth factor, Concerns About Side Effects (  = .76), consists of two items.  
Items on this factor reflect worries related to the possibility of negative effects or side effects 
from taking psychiatric medication.  High scores on this factor reflect higher levels of worry 
related to the side effects of taking prescribed psychiatric medication. 
A Factor Analysis of Variance was also conducted for the RBQ.  Table 11 presents 
variance data using Rotated Sums Squared Loadings of the individual factors of the RBQ.  
Percentage of variance and cumulative variance are presented for each factor.  Factor 1 
accounts for the largest percentage of variance at 19.63 % of the total variance (56.14 %). 
 
  
Table 10 
 
Factor Loadings of the of the RBQ 
  
Factor 1: Embarrassment/ 
Stigma (  = .85) 
Item Item 
Loading 
 15. I am embarrassed about being in treatment, even 
though I know I need it. 
.85 
 16.  People will think I’m crazy if I tell them I am under 
psychiatric care. 
.81 
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 17.  I feel ashamed when I talk about my problems. .72 
 18.  I worry about people in my life knowing that I am in 
psychiatric treatment. 
.77 
 20.  I’m too busy to follow up with aftercare.  I’ve got a 
lot of other priorities that come first like family, 
work and childcare. 
.56 
Factor 2: Unrealistic 
Optimism (  = .61) 
Item Item 
Loading 
 6.  I might need to take psychiatric medication even 
when I am feeling better. (reversed item) 
.59 
 11.  My discharge from this program means that I am 
fully recovered from my problems. 
.76 
 12. I feel better now, so I must be better.  I don’t need to 
do anything else like going to appointments, taking 
medication, or doing self-help homework. 
.82 
 13. All I have to do is stay away from the wrong people 
and I’ll be OK. 
.68 
Factor 3: Pessimism/ 
Hopelessness (  = .79) 
Item Item 
Loading 
 2.  Having a mental illness means I’ll never get better. .75 
 3.  I have little faith in getting better, no matter what kind 
of treatment I receive. 
.82 
 4.  Nothing can ever help me. .82 
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Factor 4: Concerns About 
Side Effects (  = .76) 
Item Item 
Loading 
 7.  Taking medication will probably make me feel like a 
zombie. 
.65 
 8.  I worry about becoming too dependent on my 
medication. 
.69 
 
 
Table 11 
 
Explanation of Variance by Factors using Rotated Sums of Squared Loadings 
 
 
Factor % of Variance Cumulative % 
1 19.64 19.64 
2 15.27 34.91 
3 12.76 47.67 
4 8.47 56.14 
 
 
Correlation of the RBQ Factor Scores 
  
Table 12 presents the intercorrelation of the RBQ factors.  Pearson Product Moment 
Coefficients were computed and are presented.  The most highly correlated factors were 
Factor 4, Concerns About Side Effects, with Factor 1, Embarrassment/ Stigma (r = .478, p < 
.01).  The second highest correlated factors were Factor 1, Embarrassment/ Stigma with 
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Factor 3, Pessimism/ Hopelessness (r = .396, p < .01).  Factor 3, Pessimism/ Hopelessness 
was also correlated with Factor 4, Concerns About Side Effects (r = .294, p < .05). 
 
Table 12 
Pearson Inter-correlation Matrix of RBQ Factors 
 
 
 Factor 1 Factor 2 Factor 3 Factor 4 
Factor 1 - .172 .396* .478* 
Factor 2 - - .153 -.020 
Factor 3 - - - .294* 
Factor 4 - - - - 
* Correlation significant at the 0.01 level (2-tailed) 
 
 
Coefficient Alpha Reliability 
  
 Two measures of reliability were calculated to test the internal consistency of the 
RBQ, a total scale estimate of internal reliability and subscale reliability estimates.  
Chronbach’s coefficient alpha reliability analysis was conducted.  Table 13 presents alpha 
scores for the total scale and for each factor.   
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Table 13 
 
Coefficient Alpha Reliability for the RBQ 
 
Factor Description Coefficient Alpha 
1 Embarrassment/ Stigma .85 
2 Unrealistic Optimism .61 
3 Pessimism/ Hopelessness .79 
4 Concerns About Side Effects .76 
 Total Scale .82 
 
  
Test-Retest Reliability 
 
 Fifty-two subjects (52 %) were administered the RBQ one week later or on their 
discharge from the hospital, whichever came first.  The mean length of time for the second 
administration of the RBQ was 5.7 days (SD = 2.27).  Test-retest reliability for the RBQ is 
.62 (p < .01) indicating a possible influence of intervening treatment on distorted styles of 
thinking between the first and second administration of the scale. 
 
Correlation of the RBQ with the DAS & BHS  
 
To test whether or not the RBQ correlated with other measures of distorted thinking, 
a correlational analysis using the Pearson Product Moment Coefficient of Correlation was 
conducted.  Total RBQ scores were correlated with total Beck Hopelessness Scale (BHS) 
scores and Dysfunctional Attitudes Scales (DAS) scores.  Additionally, total BHS scores 
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were correlated with the Pessimism/ Hopelessness factor of the RBQ.  Results are presented 
in Table 14. 
The RBQ demonstrates construct validity as evidenced by positive correlations with 
the Beck Hopelessness Scale (r = .29, p < .05).  This means that approximately 8 % of the 
variability on the BHS is attributable to differences on the RBQ; the other 92 % is 
attributable to other factors.   A positive correlation was also obtained for the RBQ and the 
Dysfunctional Attitudes Scale (r = .46, p < .01), which also measure distorted styles of 
thinking.  This means that approximately 21 % of the variability on the DAS is attributable to 
differences on the RBQ, and the other 79 % is due to other factors.  Total BHS scores also 
correlate with the Pessimism/ Hopelessness (PES/HOP) factor of the RBQ (r = .41, p < .01).  
This factor was also highly correlated with total RBQ scores (r = .65, p < .01).  Additionally, 
the unrealistic optimism factor (UNREAL) was negatively correlated with total BHS scores 
(r = -.187, p < .05). 
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Table 14 
Correlation of the RBQ with other Measures 
 
 UNREAL BHS DAS PES/HOP 
RBQ - .289* .463* .647* 
BHS -.187** - .478* .414* 
DAS - - - .377* 
PES/HOP - - - - 
*Correlation significant at the 0.01 level (one-tailed) 
** Correlation significant at the 0.05 level (one-tailed) 
 
Comparison of Recidivists and Non-Recidivists 
 
A Chi Square analysis revealed no significant difference between groups on 
diagnosis, gender, marital status, ethnicity, employment status, housing condition and 
educational level; suggesting homogeneity of the two groups.  Total RBQ scores for 
recidivists (mean = 15.74; SD = 9.9) did not differ significantly from non-recidivists (mean = 
15.88; SD = 8.20).  Although no significant difference was found between groups on total 
RBQ scores, non-recidivists scored significantly higher than recidivists on the Concerns 
About Side Effects factor of the RBQ (t = 2.07, df = 91, p < .05).  The mean score on this 
factor for recidivists was .96 (SD = 1.09) compared with a mean score of 1.53 (SD = 1.26) 
for non-recidivists.  Total BHS scores were significantly correlated with recidivism (r = .263, 
p < 0.01); however, no significant correlation was found for the Unrealistic Optimism factor. 
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Correlation of the RBQ with Compliance with Treatment Ratings 
 
Subjects’ self-reported compliance with treatment scores did not significantly 
correlate with total RBQ scores (r = -.049, p < .763).  Furthermore, total RBQ scores did not 
significantly correlate with clinician rated treatment compliance scores (r = .194, p < .258).  
However, taking more medication than prescribed, as reported by treating clinicians, is 
positively correlated with total RBQ scores (r = .38, p < .05).   
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Discussion 
 
 The aim of this study was to design a self-report inventory that could measure the 
presence of specific types of distorted beliefs related to the process of recovery from 
psychiatric illness.  The results of this study indicate that this has been accomplished.  This 
chapter, in addition to summarizing the results of the study, and discussing the relevancy of 
the findings to the existing literature, will also cite the limitations of the current investigation.  
There is also a discussion of recommendations for future research. 
 
Discussion of Research Findings 
 
 In this study the Zahn-Given Recovery Beliefs Questionnaire was developed and its 
psychometric properties were examined.  A preliminary validation of the RBQ was 
conducted using a sample of 100 psychiatric inpatients.  Positive psychometric properties 
were obtained, including (a) acceptable levels of internal consistency as evidenced by 
coefficient alpha reliability scores; (b) acceptable levels of content validity as evidenced by 
100 % agreement in the retention and sorting of scale items through expert review; and (c) 
acceptable levels of construct validity as evidenced by a factor structure that includes four of 
the hypothesized subscales (Embarrassment/ Stigma, Unrealistic Optimism, Pessimism/ 
Hopelessness, and Concerns About Side Effects), as well as positive correlations with the 
BHS and DAS.  In addition, a positive correlation between total BHS score and the 
Pessimism/ Hopelessness factor of the RBQ was noted; a negative correlation between the 
Unrealistic Optimism factor and the BHS was also obtained.   
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Demographic Characteristics 
 
 A preliminary validation of the RBQ was conducted using a sample of hospitalized 
psychiatric patients.  A criterion was established to distinguish a subset of patients who were 
identified as recidivists.  Results of demographic data analysis indicated that the two groups 
(e.g., recidivists and non-recidivists) were equally representative, with no significant 
differences found in diagnosis, gender, marital status, ethnicity, employment status, housing 
condition and educational level.   
 One purpose of this study was to identify whether or not recidivists endorsed more 
distorted recovery-related beliefs compared with non-recidivists as evidenced by total RBQ 
scores.  It was hypothesized that recidivists would have a tendency to view recovery from 
psychiatric illness in more distorted ways, as evidenced by non-adherence to outpatient 
treatment and more frequent re-hospitalization.   Results of the study indicated no significant 
difference on total RBQ scores between groups; therefore, this hypothesis was not supported.   
Recidivists obtained a total RBQ mean score of 15.74 (S.D. = 9.9) and non-recidivists 
obtained a mean score of 15.88 (S.D. = 8.20).  One possible explanation for this non-
significant difference relates to the sample size and distribution of recidivists and non-
recidivists.  A sample size of 100 was used to obtain a ratio of 5:1 for number of subjects to 
number of scale items.  Although this ratio was achieved, many validation studies of new 
psychometric instruments use much larger sample sizes.  Additionally, less than a third of the 
total sample (31%, n = 31) was composed of recidivists.  Using a larger sample size with a 
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more equal distribution of recidivists and non-recidivists may have revealed a statistically 
significant difference on total RBQ scores.   
The only demographic variable that was significantly correlated with total RBQ 
scores was related to use of prescription medication.  Subjects who were reported taking 
more medication than was prescribed, as evidenced by responses from treating clinicians, 
obtained a significant correlation with total RBQ scores (r = .38, p < .05).  This suggests that 
patients who are liable to overuse their prescription medication possess more distorted views 
about the process of recovery from psychiatric illness than those who do not.  One possible 
explanation for this may be a coping skills deficit, which causes individuals to have poorly 
developed responses to situational stress or affective disturbance.  Such individuals may 
possess an external locus of control and underestimate their ability to affect positive change.  
As such these patients may have a tendency to “self-medicate” during times of increased 
stress.   
Compliance with treatment data reveals that 68% (n = 68) of subjects reported taking 
medication within the previous six months or since their last hospitalization (if fewer than six 
months).  Of the 32% (n = 32) not taking medication, half of this group (50%, n =16) 
reported not taking medication even when it was recommended in the past.  Furthermore, 
44% (n = 44) of subjects were not attending any type of outpatient treatment at the time of 
their hospitalization even when it had been recommended to 71% (n = 31) of this group.  
Possible explanations for this include lack of resources (e.g., not having health insurance), 
concerns about side effects, embarrassment, stigmatization, or other distorted beliefs (e.g., “I 
should be able to handle my problems on my own”, or “Taking medication is a sign of 
weakness”).  There was not enough data to determine whether or not total RBQ scores for 
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patients who were non-compliant with recommended treatment were significantly different 
from those who sought treatment and dropped out prematurely.  
 
Content Validity 
 
  
The RBQ appears to demonstrate acceptable content validity as established by a panel 
of experts and by factor analysis.  The RBQ items were developed using clinical experience 
and relevant literature. The items were designed as self-statements that reflected distorted 
views related to recovery from psychiatric illness.  Once a final item pool had been created, 
three independent experts assisted in the development of the scale items.  All of the items and 
definitions were subject to a comprehensive review that included (a) cognitive factor 
definition for construct accuracy (b) item content for grammar and clarity and (c) 
independent sorting of items into related cognitive factors.  Of the 62 originally pooled items 
only 20 items were retained, which reflect 100% agreement on the selection and sorting of 
scale items into related variables.   
 
Construct Validity 
 
 A panel of three independent experts was used to establish the construct validity of 
the RBQ.  Experts were asked to decide whether or not the 14 proposed variables reflected 
the “universe” of cognitive factors believed to be important in the process of recovery from 
psychiatric illness.  One reviewer suggested an additional category regarding the “therapeutic 
alliance”.   Although this is believed to be an important factor related to treatment adherence, 
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the two other experts believed that the alliance was subsumed under other factors.  Two 
factors, “paralysis of will” and “hostility”, were eliminated during the review process due to 
lack of consensus among expert reviewers.   A criterion of 100% agreement between 
independent experts was achieved for the 12 factors selected for final inclusion in the 
instrument.  Although there may be many other factors related to the nature of the research 
question, there was an attempt made on the part of the researcher to limit the scope of the 
instrument.  Failure to do so would have led to the development of a rather lengthy and 
impractical assessment tool. 
 To establish the construct validity of the RBQ, a correlational analysis was conducted 
using the BHS and the DAS.  These two measures were used because they both reflect 
distorted and dysfunctional ways of thinking.  The BHS was used primarily to determine 
whether or not the construct of pessimism and hopelessness as evident in the 
Pessimism/Hopelessness (PES/HOP) factor of the RBQ correlated positively with an 
established measure of hopelessness.  A positive correlation was obtained (r = .414, p < .01) 
indicating that the PES/HOP factor reflects the construct that it was intended to measure.  As 
predicted, the Unrealistic Optimism (UNREAL) factor of the RBQ correlated negatively with 
total BHS scores (r = -.187, p < .05).  Because the UNREAL factor reflects overly optimistic, 
simplistic and naïve recovery-related beliefs, it stands to reason that subjects who score 
higher on this factor would also show lower levels of hopelessness. 
 Total scores obtained on the RBQ were also correlated with total DAS scores (r = 
.463, p < .01).  Additionally, BHS scores were correlated with total RBQ scores (r = .289, p < 
.01).  This suggests that subjects with distorted recovery-related beliefs as measured by the 
RBQ tend to possess more global dysfunctional attitudes and levels of hopelessness. 
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Factor Analysis of the RBQ 
 
 A principal component, varimax rotated factor analysis was conducted using Kaiser’s 
Criterion.  Results obtained from the factor analysis yielded significant results for the internal 
structure of the scale.  A total of six factors with eignvalues greater than one were extracted.  
Using a factor loading criterion of .55 or greater, four factors were retained.  Fourteen of the 
20 items of the RBQ loaded on these factors.  Of the total scale variance, 56.14% was 
accounted for by four factors: Embarrassment/ Stigma, Unrealistic Optimism, Pessimism/ 
Hopelessness, and Concerns About Side Effects.  These factors reflect four of the originally 
hypothesized subscales of the RBQ.  The following is a description of each factor. 
 Factor 1, Embarrassment/ Stigma included five items.  This factor, accounting for the 
largest single variance of all the factors in the scale (See Table 11), appears to tap into fear of 
negative evaluation from others.  High scores on this factor, as it relates to the need for 
psychiatric treatment, reflect higher levels of shame, embarrassment and fear of being judged 
by others. Those who score high on factor 1 believe that needing or seeking professional help 
is something to be embarrassed and ashamed about.  Also, they may worry that others will 
think of them as “crazy” or defective if they reveal their need for treatment.  The underlying 
distorted belief appears to be, “I should be able to handle my problems on my own”.  Factor 
1 also correlated with Pessimism/ Hopelessness (r = .396, p < .01) and Concerns About Side 
Effects (r = .478, p < .01).  This suggests that individuals who experience higher levels of 
shame and embarrassment also possess higher levels of hopelessness and more concerns 
related to treatment. 
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 Factor 2, Unrealistic Optimism consists of four items.  High scores on this factor 
reflect an overly optimistic and unrealistic view of recovery.  Subjects endorsing items on 
this factor tend to view the recovery from psychiatric illness in a simplistic or naïve fashion.  
They may fail to anticipate any difficulties or to develop appropriate relapse prevention plans 
if such difficulties should arise.  There may be a tendency for such individuals to seek 
treatment only when there is a crisis.  In an exploratory analysis it was noted that Factor 2 
correlates negatively with self-reported compliance with treatment scores (r = -.348, p < .05).  
This suggests that individuals with higher levels of unrealistic optimism tend to be less 
compliant with recommended treatment.  Also, there is anecdotal evidence that many patients 
decompensate and require re-hospitalization because of these types of beliefs.  For example, 
one patient recently said “I was feeling better so I stopped taking my medication…I thought I 
was better”.  Indeed, this individual probably was doing better, not in spite of the medication, 
but because of the medication.  Stopping her medication when she was feeling better reflects 
the type of thinking that factor 2 attempts to measure.  Factor 2 would benefit from further 
development, given its lower alpha level. 
 Factor 3, Pessimism/ Hopelessness, consists of three items.  This factor appears to 
measure overly distorted and negative views about recovery.  Subjects who score high on this 
factor have little faith in getting better.  They perceive treatment in a negative light and feel 
that nothing can help them overcome their current distress.  High scores on this factor reflect 
high levels of pessimism and hopelessness related to treatment.  This factor appears to be 
state-dependent, as is the BHS, and such beliefs might shift as patients experience subjective 
relief during the course of their treatment.   
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 Factor 4, Concerns About Side Effects, consists of two items.  High scores on this 
factor reflect worries related to side effects from psychiatric medication.  The concerns 
reflected in these items involve impairment in functioning (e.g., feeling like a “zombie”) and 
dependency (i.e., not being able to cope without the medication).  It is conceivable that 
individuals who score higher on this factor are less compliant with recommended medication. 
 In conclusion, factor analyses of the RBQ yielded four separate, underlying factors or 
subscales closely matching the originally hypothesized factors.    
 
 
Reliability of the RBQ  
 
 Two measures were used to test the internal consistency of the RBQ.  This included a 
total scale estimate of internal reliability as well as subscale estimates of internal reliability.  
The total RBQ scale had a Cronbach’s alpha of .82.  Coefficient alpha levels for subscales 
are as follows: Embarrassment/ Stigma (.85), Unrealistic Optimism (.61), Pessimism/ 
Hopelessness (.79) and Concerns About Side Effects (.76).  These results suggest that the 
RBQ demonstrates acceptable levels of internal consistency among items and overall scale 
content.  Furthermore it suggests that the RBQ is a valid measure of four factors that are 
derived from relevant research in understanding treatment non-adherence.  Factor 2, 
Unrealistic Optimism, would benefit from further development, given its lower alpha level.  
Future investigations should include additional scale items to boost the reliability of this 
factor. 
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 The test-retest reliability of the RBQ was also analyzed.  The total test-retest 
reliability for the RBQ was .62 (p < .01).  An attempt was made to administer the RBQ one 
week after completing the first administration of the scale; however, this was not always 
possible due to some subjects having a length of stay less than a week.  A total of 52 (52%) 
subjects completed the re-test of the RBQ.  Subjects who left the hospital prior to the one-
week interval were administered the scale on their day of their discharges.  The mean number 
of days between the first and second administration was 5.7 days (SD = 2.27).   
 To understand the test-retest reliability of the RBQ, it is important to consider the 
influence of intervening treatment between administrations.  Subjects who came into the 
hospital received intensive treatment, including medication, group therapy, individual 
therapy and activity based therapies.  Many of the treatments may have directly impacted on 
the belief system of the individual, particularly as he or she began to experience symptom 
relief.  For example, as levels of depression and hopelessness decreased with treatment, an 
associated decrease would also be expected on the Pessimism/ Hopelessness factor on the 
RBQ.  Additionally, subjects who initially scored high on the Concerns About Side Effects 
factor might have had fewer concerns related to their medication at re-test because they had 
an opportunity to tolerate the medication for the preceding week.  Again, a decrease in 
medication-related concerns would be expected, assuming the subjects did not experience 
any adverse reactions to their medication.  Furthermore, embarrassment and stigmatization is 
typically reduced in an inpatient setting by having open discussions around these issues and 
by direct contact with others who have experienced similar symptoms or problems.  
Physicians, therapists and nursing staff may have influenced beliefs associated with the 
Unrealistic Optimism factor through direct discussion with subjects and through the 
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educational efforts of the treatment team.  Family members or significant others may have 
been involved in the treatment process to help the patient develop an sense of increased 
support while having an opportunity to discuss relapse prevention once discharged from the 
hospital.   
 For these reasons it is understandable that the test-retest of the RBQ is lower than one 
would hope for in an instrument development and validation study.  However, reductions in 
total RBQ scores from the first administration (mean = 15.78, SD = 9.36) to the second 
administration (mean = 12.77, SD = 8.19) may be a reflection of a treatment program that 
effectively impacts on distorted recovery-related beliefs.  Also, lower test-retest reliability 
might be a reflection of state-related thinking rather than a more global and pervasive 
thinking style. The test-retest reliability of the RBQ is comparable to the re-test reliability of 
the Beck Hopelessness Scale (.66) (Beck & Steer, 1988), which is another state-dependent 
self-report instrument. 
 
Implications for Treatment 
  
 The RBQ is the first measure of its kind aimed specifically at assessing recovery-
related beliefs in psychiatric patients. The RBQ offers a formal way to assess the necessity-
concerns construct as postulated by Horne (1999) with an inpatient psychiatric population.  
The RBQ allows clinicians working with these patients the use of a formal assessment tool to 
identify potential risk factors related to treatment non-adherence and potential relapse.  One 
aim of the RBQ is to assess the patient’s attitudes or beliefs related to recovery at the onset of 
treatment.  Responses on the RBQ can be used by the treatment team to develop a focused 
and individualized treatment plan based on the patient’s responses.  In other words, the RBQ 
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can be used a first step in identifying distorted styles of thinking that may place the patient at 
risk of subsequent treatment failure and/or relapse.  If such distorted thoughts are identified 
early in the course of treatment,  they can then become a main focus of the patient’s 
treatment.  Individual therapy can help patients examine these beliefs and develop rational 
responses.  Furthermore, group programming can be used as a vehicle for exploring and 
modifying those factors measured by the RBQ.  By helping to modify or correct distorted 
recovery-related beliefs, it is hoped that patients who are discharged from the hospital will be 
more likely to comply with recommended aftercare, thus reducing the probability of relapse 
and re-hospitalization.   
 
Limitations of the Study 
 
 Although the current study aims to produce a relevant and clinically useful 
assessment tool, there are several limitations in its design.  The first relates to the sample 
size.  Although a ratio of participants to number of items of 5:1 was used, many self-report 
instruments are developed using a much larger sample size.  Furthermore, the number of 
recidivists (n = 31) in this study limits the ability to draw comparisons between groups, and 
may account for the lack of statistical significance on total RBQ scores.   
Another limitation relates to how well the results can be generalized.  Because an 
inpatient sample from one facility is being used, the results may not have captured all of the 
possible cognitive factors associated with treatment adherence and recidivism.  It is possible 
that a larger sample of psychiatric patients from different areas may have revealed different 
beliefs about psychiatric illness and its treatment.  Additionally, the proposed scale may not 
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fully capture all of the possible cognitive factors associated with treatment non-adherence 
and recidivism.  To do so would require a rather extensive and perhaps impractical 
assessment tool. Thus, there has been some effort on the part of the researcher to limit what 
is included in the scale, based on relevant research and clinical judgment.   
In addition to these limitations, the study does not include an outpatient sample 
primarily because of the nature of the research question.  However, it may be useful to 
expand the current study to explore the recovery beliefs of an outpatient treatment group 
compared with those beliefs of psychiatric inpatients.    
 
Recommendations for Future Research 
 
Recommendations for future research include adding items to weaker factors to 
strengthen the content validity of the measure.  This is especially true for the Unrealistic 
Optimism factor, given its lower alpha level.  A reassessment of the psychometric properties 
of the RBQ, using a larger sample size that includes more recidivists, is needed to draw 
comparisons between groups and to identify areas of intervention.  Also it would be 
interesting to test the factor structure of the RBQ further with both inpatient and outpatient 
populations.  Doing so would enable researchers and clinicians to identify and to intervene 
with patients at risk of treatment failure and a pattern of relapse.   Finally, it is hoped that the 
RBQ can be used as a predictive measure of recidivism.   
 
Conclusion 
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 Despite its limitations the Zahn-Given Recovery Beliefs Questionnaire provides a 
valid and reliable measure of distorted beliefs surrounding recovery from psychiatric illness.   
The RBQ possesses a factor structure that includes Embarrassment/ Stigma, Unrealistic 
Optimism, Hopelessness/ Pessimism and Concerns About Side Effects.  A total scale alpha 
reliability of .82 indicates stability of the instrument.  The RBQ demonstrates construct 
validity as evidenced by positive correlations with the BHS and DAS, which also measure 
distorted styles of thinking.  Furthermore, the Pessimism/Hopelessness factor of the RBQ 
correlates positively with the BHS.  Future studies are needed to further develop the 
psychometric properties of the instrument to make it useful tool in clinical practice.   
64 
 
References 
 
American Psychiatric Association (2000). Diagnostic and statistical manual of mental 
disorders, fourth edition, text revision. APA.  
Beck, A. T. (1976). Cognitive therapy and the emotional disorders. New York: International 
Universities Press. 
Beck, A. T. & Steer, R. A. (1988). Beck hopelessness manual. San Antonio, TX: 
Psychological Corporation.  
Beck, A. T., Weissman, A., Lester, D. & Trexler, L. (1974). The measurement of pessimism: 
The Hopelessness Scale. Journal of Consulting and Clinical Psychology, 42, 861-
865. 
Booth-Kewley, S. & Vickers, R. R. (1994). Associations between major domains of 
personality and health behavior. Journal of personality, 62, 281-298. 
Bordin, E. S. (1976). The generalizability of the psychoanalytic concept of the working 
alliance. Psychotherapy: Theory, research and practice, 16, 252-260.  
Bordin, E. S. (1994). Theory and research on the therapeutic working alliance: New 
directions. In A. Horvath & L. Greenberg (Eds.), The working alliance: Theory 
research and practice (pp. 13-37). New York: John Wiley & Sons, Inc.  
Budd, R. J., Hughes, I. C. T., & Smith, J. A. (1996). Health beliefs and compliance with 
antipsychotic medication. British journal of clinical psychology, 35, 393-397. 
Carpenter, M. D., Mulligan, J. C., Bader, I. A., Meinzer, A. E., (1985). Multiple admissions 
to an urban psychiatric center: A comparative study. Hospital and community 
psychiatry, 36, 1305-1308. 
65 
 
Casper, E. S. & Donaldson, B. (1990). Subgroups in the population of frequent users of 
inpatient services. Hospital and community psychiatry, 41, 189-191.  
Casper, E. S., Romo, J. M., & Fasnacht, R. C. (1991). Readmission patterns of frequent users 
of inpatient psychiatric services. Hospital and community psychiatry, 42, 1166-1167. 
Christensen, A. J., Moran, P. J. & Wiebe, J. S. (1999). Assessment of irrational health 
beliefs: Relation to health practices and medical regimen adherence. Health 
psychology, 18, 169-176. 
Cochran, S. D. & Gitlin, M. J. (1988). Attitudinal correlates of lithium compliance in bipolar 
affective disorders. Journal of nervous and mental disease, 176, 457-464. 
Delgado, P. L. (2000). Approaches to the enhancement of patient adherence to antidepressant 
medication treatment. Journal of clinical psychiatry, 61 (suppl 2), 6-9. 
Freeman, Pretzer, Fleming & Simon (1990). Clinical applications of cognitive therapy (p. 5). 
New York: Plenum Press. 
Garavan, J., Browne, S., Gervin, M., Lane, A., Larkin, C. & O'Callaghan, E. (1998). 
Compliance with neuroleptic medication in outpatients with schizophrenia: 
Relationship to subjective response to neuroleptics; attitudes to medication and 
insight. Comprehensive psychiatry, 39, 215-219. 
Goodpastor, W. A., Hare, B. K. (1991). Factors associated with multiple admissions to an 
urban -public psychiatric hospital. Hospital and community psychiatry, 42, 85-87. 
 Geller, J. L. (1986). In again, out again: Preliminary evaluation of a state hospital's worst 
recidivists. Hospital and community psychiatry, 37, 386-390. 
Green, J. H. (1988). Frequent rehospitalization and noncompliance with treatment. Hospital 
and community psychiatry, 39, 963-966. 
66 
 
Harris, M., Bergman, H. C., & Bachrach, L. L. (1986). Psychiatric and nonpsychiatric 
indicators for rehospitalization in a chronic patient population. Hospital and 
community psychiatry, 37, 630-631. 
Haywood, T. W., Kravitz, H. M., Grossman, L. S., Cavanaugh, J. L., Davis, J. M., & Lewis,  
D. A. (1995). Predicting the "revolving door" phenomenon among patients with 
schizophrenic, schizoaffective, and affective disorders. American journal of 
psychiatry, 152, 856-861. 
Horne, R. (1997). Representations of medication and treatment: Advances in theory and 
measurement. In Petrie, K. J. & Weinman, J. (Eds.). Perceptions of health and 
illness: Current research and applications. London: Harwood, pp. 155-187. 
Horne, R. (1999). Patients' beliefs about treatment: The hidden determinant of treatment 
outcome? Journal of psychosomatic research, 47, 491-495. 
Horne, R. & Wienman, J. (1999). Patients' beliefs about prescribed medicines and their role 
in adherence to treatment in chronic physical illness. Journal of psychosomatic 
research, 47, 555-567. 
Horne, R, Weinman, J. & Hankins, M. (1999). The beliefs about medicines questionnaire 
(BMQ): A new method for assessing cognitive representations of medication. Psychol 
health, 1-29. 
Horvath, A. O. & Luborsky, L. (1993). The role of the therapeutic alliance in psychotherapy. 
Journal of consulting and clinical psychology, 61 (4), 561-573. 
Kemp, R., Hayward, P., Applewhaite, G., Everitt, B., & David, A. (1996). Compliance 
therapy in psychotic patients: A randomized controlled trial. British medical journal, 
312, 345-349. 
67 
 
Leventhal, H., Diefenbach, M., Leventhal, E. A. (1992). Illness cognition: Using common 
sense to understand treatment adherence and affect cognition interactions. Cognitive 
therapy and research, 16, 143-163. 
Leventhal, H., Nerenz, D. & Steele, D. J. (1984). Illness representations and coping with 
health threats. In A. Baum, S. E. Taylor &  J. E. Singer (Eds.), Handbook of 
psychology and health (pp. 219-252). Hillsdale, NJ: Erlbaum. 
Marlatt, G. A. & Gordon, J. R. (Eds.) (1985). Relapse prevention: Maintenance strategies in 
the treatment of addictive behaviors. New York: Guilford Press. 
Meichenbaum, D. & Turk, D. (1987). Facilitating treatment adherence: A practioner’s 
guidebook.  New York & London: Plenum Press. 
Miller, W. R. & Tonigan, J. S. (1996). Assessing drinkers' motivation for change: The stages 
of change and readiness and treatment eagerness scales (SOCRATES). Psychology of 
addictive behaviors, 10, 81-89. 
Myers, M. G., Martin, R. A., Rohsenow, D. J. & Monti, P. M. (1996). The relapse situation 
appraisal questionnaire initial psychometric characteristics and validation. Psychology 
of addictive behaviors, 10, 237-247. 
Nelson, E. A., Maruish, M. E.& Axler, J. L. (2000). Effects of discharge planning and 
compliance with outpatient appointments on readmission rates. Psychiatric services, 
51 (7), 885-889. 
Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance 
and substance abuse among patients with schizophrenia. Psychiatric services, 47, 
853-858. 
68 
 
Prochaska, J. O. & DiClemente, C. C. (1982). Transtheoretical therapy: Towards a more 
integrative model of change. Psychotherapy, 19, 276-278. 
Rogers, C. (1951). Client centered therapy. Cambridge, MA: Riverside Press. 
Rosenstock, I. M. (1966). Why people use health services. Milbank memorial fund quarterly, 
44, 94-127. 
Rosenstock, I. M. (1974). Historical origins of the health belief model. Health education 
mongraphs, 2, 328-335. 
Rotter, J. B. (1966). Generalized expectancies for internal versus expectancies for external 
control of reinforcement. Psychological monographs, 80, 609-615. 
Smith, K., Subich, L. & Kaldoner, C. (1995). The transtheoretical model's stages and 
processes of change and their relation to premature termination. Journal of counseling 
psychology, 42, 34-39. 
Surber, R. W., Winkler, E. L., Monteleone, M., Havassy, B. E., Goldfinger, S. M., & Hopkin, 
J. T. (1987). Characteristics of high users of acute psychiatric inpatient services. 
Hospital and community psychiatry, 38, 1112-1114. 
U.S. Department of Health and Human Services (1999). Mental health: A report of the 
surgeon general. Rockville, MD: U.S. Dept. of Health & Human Services. 
Weinman, J., Petrie, K. J., Moss-Morris, R., & Horne, R. (1996). The illness perception 
questionnaire: A new method for assessing cognitive representations of illness. 
Psychol health, 431-446. 
Weinman, J. & Petrie, K. (1997). Illness perceptions: A new paradigm for psychosomatics? 
Journal of psychosomatic research, 42, 113-116. 
69 
 
Weinstien, N. D. (1982). Unrealistic optimism about susceptibility to health problems. 
Journal of behavioral medicine, 5, 441-460. 
Weinstien, N. D. (1983). Reducing unrealistic optimism about illness susceptibility. Health 
psychology, 2, 11-20. 
Weinstien, N. D. (1984). Why it won't happen to me: Perceptions of risk factors and 
susceptibility. Health psychology, 3, 431-457. 
Weissman, A. N. (1979). The dysfunctional attitude scale: A validity study. Dissertation 
abstracts, 40, 1389-1390. 
Wiebe, J. S. & Christensen, A. J. (1996). Patient adherence in chronic illness: Personality and 
coping in context. Journal of personality, 64, 815-835. 
World Health Organization (WHO) (2001). The world health report 2001- mental health: 
New understanding, new hope. Geneva, World Health Organization. 
70 
 
Appendices 
Appendix A: Proposed Scale Items Prior to Expert Review 
Reasons Why Patients May Decide Not to Adhere to Treatment 
(Adapted from Meichenbaum & Turk, 1987) 
 
Uncertainty about the efficacy of treatment 
 I am not sure that going to therapy or taking medication will do me any good. 
 It’s not likely that treatment will help me with my problems. 
 I don’t think that talking to a therapist will help. 
 
Prior experience with illness and changes in patient’s health 
 I can usually get better on my own. 
 I think this problem will go away by itself. 
 Things will only get worse for me no matter what I do. 
 I have not found treatment helpful in the past. 
 Talking about my problems only makes me feel worse. 
 
Expectations about symptoms, illness, health care providers, and treatment 
 I will always experience emotional problems because I have a chemical imbalance. 
 Having a mental illness means I’ll never get better. 
 Most therapists and doctors don’t know how to help me. 
 I might need to take psychiatric medication after I leave treatment here, even though I am 
feeling better now. 
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 Once I start feeling better, I might decide to stop taking my medication or going to my 
aftercare program. 
 I expect to have a lot of ups and downs during my recovery. 
 
Past experiences with health care providers 
 Therapists cannot be trusted. 
 Most people I’ve seen don’t know how to help me with my problems.  
 I have not found going to therapy very helpful to me. 
 Therapists usually have their own agenda. They really aren’t interested in what I have to 
say. 
 I have a hard time speaking up when I am dissatisfied with my treatment. 
 
Concerns about possible side effects 
 I don’t know if I can handle my feelings if I talk about them in therapy. 
 I don’t always follow my doctor’s instructions because I am concerned about possible 
side effects. 
 Taking medication will probably make me feel like a zombie. 
 I worry about becoming too dependent on my medication. 
 
Determination that costs outweigh benefits 
 Therapy will probably only make things worse for me. 
 I can’t think of enough good reasons to stick with my outpatient treatment. 
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 I have more important things to do with my time other that going to my psychiatric 
appointments. 
 
Embarrassment about being in treatment 
 I am embarrassed about being in psychiatric treatment even though I know I need it. 
 I feel ashamed when I talk about my problems. 
 People will think I’m crazy if I tell them I am under psychiatric care. 
 
Pessimism or skepticism about the effectiveness of treatment 
 I am very doubtful about how helpful treatment is likely to be for me. 
 I have little faith in ever getting better, no matter what kind of treatment I receive. 
 Nothing can ever help me. 
 My problems are always going to be there, whether or not I am in psychiatric treatment. 
 
Impatience with the level of progress or the treatment process 
 I get frustrated with my lack of progress. 
 I don’t know if I can wait that long for things to start improving. 
 If things don’t change soon, then what’s the use? 
 If I didn’t feel better after a few appointments, I would probably stop going to treatment. 
 
Competing demands that are deemed more important 
 I have more important things to do with my time other than going to therapy. 
 Going to treatment interferes with things that are more important to me.  
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 I don’t have the time that it takes to keep going to my treatment sessions. 
 I'm too busy to follow-up with aftercare.  I've got a lot of other priorities that come first 
like family, work and child care. 
 
Paralysis of will  
 I don’t have the desire or motivation to stay in treatment. 
 It seems like I can’t motivate myself to do things that might help me, like going to 
therapy or taking medication. 
 I stopped caring about going to treatment sessions. 
 I've been depressed for so long, there's nothing I can do about it. 
 
Viewing treatment as interfering with future plans, relationships, self-concept or daily life 
 Going to treatment sessions will only get in the way of my plans. 
 I worry about people in my life knowing that I am in psychiatric treatment. 
 If I was a stronger person I wouldn’t need psychiatric care. 
 Following my doctor's orders means that I'm really not in control of my life.  It's better to 
do things my way. 
 People should learn to help themselves. 
I am concerned that treatment will change me in ways that I don’t like or want. 
 
Additional Items under Investigation 
 
Unrealistic Optimism 
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 My discharge from this program means that I am fully recovered from my problems. 
 I feel better now, so I must be better. I don't need to do anything else like going to 
appointments, taking medication, or doing self-help homework. 
 I don’t think I have to do anything else to stay healthy.  I came to this program to get 
better, now I am better. 
 All I have to do is to stay away from the wrong people and I'll be OK. 
 
Hostility 
 Other people should get their act together before expecting me to do the same. 
 I can take care of my problems without other people telling me what to do. 
 If the staff did their job while I was here in the hospital, I wouldn't have to follow-up with 
aftercare to keep myself healthy. 
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Appendix B: Final Instrument 
ZAHN-GIVEN RECOVERY BELIEFS QUESTIONNAIRE 
Name: _______________________________  Date: ___________ 
Directions: This questionnaire consists of 20 statements. Please read each statement carefully. Circle 
the number that best describes how strongly you believe each statement.  Use the scoring key below 
to indicate your response.  Do not leave any statements blank. 
 
HOW MUCH DO YOU BELIEVE 
THIS STATEMENT? 
Not at All Slightly Moderately Very 
Much 
Totally Does Not 
Apply 
1. I don’t think that treatment will help 
me with my problems. 
0 1 2 3 4 5 
2. Having a mental illness means I’ll 
never get better. 
0 1 2 3 4 5 
3.  I have little faith in ever getting 
better, no matter what kind of 
treatment I receive. 
0 1 2 3 4 5 
4. Nothing can ever help me. 0 1 2 3 4 5 
5. I’ve been depressed for so long, 
there’s nothing I can do about it. 
0 1 2 3 4 5 
6. I might need to take psychiatric 
medication even when I am feeling 
better. 
0 1 2 3 4 5 
7. Taking medication will probably 
make me feel like a zombie. 
0 1 2 3 4 5 
8. I worry about becoming too 
dependent on my medication. 
0 1 2 3 4 5 
9. If I don’t feel better after a few 
appointments, I’ll probably stop 
going to treatment. 
0 1 2 3 4 5 
10. I have not found treatment helpful in 
the past. 
0 1 2 3 4 5 
11. My discharge from this program 
means that I am fully recovered from 
my problems. 
0 1 2 3 4 5 
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HOW MUCH DO YOU BELIEVE 
THIS STATEMENT? 
Not at All Slightly Moderately Very 
Much 
Totally Does Not 
Apply 
12. I feel better now, so I must be better.  
I don’t need to do anything else like 
going to appointments, taking 
medication, or doing self-help 
homework. 
0 1 2 3 4 5 
13. All I have to do is stay away from 
the wrong people and I’ll be OK. 
0 1 2 3 4 5 
14. I can take care of my problems 
without other people telling me what 
to do. 
0 1 2 3 4 5 
15. I am embarrassed about being in 
treatment, even though I know I need 
it. 
0 1 2 3 4 5 
16. People will think I’m crazy if I tell 
them I am under psychiatric care. 
0 1 2 3 4 5 
17. I feel ashamed when I talk about my 
problems. 
0 1 2 3 4 5 
18. I worry about people in my life 
knowing that I am in psychiatric 
treatment. 
0 1 2 3 4 5 
19. I don’t have the time that it takes to 
keep going to my treatment sessions. 
0 1 2 3 4 5 
20. I’m too busy to follow-up with 
aftercare. I’ve got a lot of other 
priorities that come first like family, 
work and childcare. 
0 1 2 3 4 5 
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Appendix C: Compliance with Treatment Form (Subject) 
  
Section A 
  
Please answer the following questions: 
 
1.  Have you taken any psychiatric medication (i.e., for mental health reasons) in the 
past 6 months, or since your last hospitalization? _____Yes _____ No 
1A. If no, has anyone ever recommended that you take psychiatric 
medication? _____Yes _____ No 
2. Have you seen a therapist or attended an outpatient program (e.g., partial hospital, 
intensive outpatient program) within the past 6 months, or since your last 
hospitalization? _____Yes (go to 2A) _____ No (go to 2B) 
2A. If yes, did you complete the treatment?  
_____Yes _____ No _____ Still in progress 
2B. If no, has anyone recommended that you see a therapist or attend 
an outpatient program? _____Yes _____ No 
 
If you answered “yes” to question 1 or 2 proceed to Section B.  If you answered 
“no” to both 1 and 2 you are finished. 
 
Section B 
Instructions: Read each item carefully and select the number that best describes your 
behavior in the past 6 months or since your last hospitalization.  Please answer 
honestly since your responses will in not negatively affect your current treatment.  
Please use the following scale:  
 
0 = does not apply 
1 = totally agree 
2 = agree somewhat  
3 = neutral   
4 = disagree somewhat  
5 = totally disagree 
 
_____  I consistently attend appointments with my outpatient psychiatrist. 
_____  I take my prescribed medication consistently and as directed by my doctor. 
_____  I forget to take my medication at times. 
_____  At times, I have taken more medication than what was prescribed for me. 
_____  At times I have taken less medication than what was prescribed for me.  
_____  I attend appointments with my therapist and/or program on a regular basis. 
_____  I have dropped out of treatment before completing it. 
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Appendix D: Compliance with Treatment Form (Clinician) 
Section A 
  
Please answer the following questions: 
 
1.  Has the patient taken any psychiatric medication in the past 6 months, or since 
their last hospitalization? _____Yes _____ No 
1A. If no, has anyone ever recommended that the patient take 
psychiatric medication? _____Yes _____ No 
2. Has the patient seen a therapist or attended an outpatient program (e.g., partial 
hospital, intensive outpatient program) within the past 6 months, or since their 
last hospitalization? _____Yes (go to 2A) _____ No (go to 2B) 
2A. If yes, did they complete the treatment?  
_____Yes _____ No _____ Still in progress 
2B. If no, has anyone recommended that that the patient see a therapist 
or attend an outpatient program? _____Yes _____ No 
 
If you answered “yes” to question 1 or 2 proceed to Section B.  If you answered 
“no” to both 1 and 2 you are finished. 
 
Section B 
Instructions: Please select the number that best describes your patient’s behavior in the past 
6 months or since their last hospitalization using the following scale:  
 
0 = does not apply 
1 = totally agree 
2 = agree somewhat  
3 = neutral   
4 = disagree somewhat  
 5 = totally disagree 
 
_____  The patient is consistent in attending appointments with his/her outpatient 
psychiatrist. 
_____  The patient takes prescribed medication consistently and as directed. 
_____  The patient forgets to take medication at times. 
_____  The patient sometimes takes more medication than what is prescribed. 
_____  The patient sometimes takes less medication than what is prescribed.  
_____  The patient attends appointments with his/her outpatient therapist and/or 
program on a regular basis. 
 _____  The patient drops out of treatment before completion. 
 
